Recent Quotes
My Watchlist
Indicators
Local Stocks
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zoetis (NY:ZTS)

126.65 +1.01 (+0.80%)
Official Closing Price Updated: 7:00 PM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zoetis

< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
News headline image
ZTS Q4 Deep Dive: Product Innovation and Competitive Pressures Shape Outlook
Animal health company Zoetis (NYSE:ZTS) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 3% year on year to $2.39 billion. The company expects the full year’s revenue... 
Via StockStory
News headline image
Analysts Question Zoetis&#39; Pathway To Growth As Key Segments Slide ↗
Animal health firm Zoetis Inc. (NYSE: ZTS) reports Q4 2025 earnings, with adjusted EPS of $1.48 beating consensus of $1.40. 
Via Benzinga
News headline image
Zoetis (ZTS) Q4 2025 Earnings Call Transcript ↗
Zoetis (ZTS) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Bonds Earnings
News headline image
Zoetis Inc. (ZTS): Navigating Innovation and Safety in a Mature Animal Health Market
Zoetis Inc. (NYSE: ZTS) stands today as the undisputed global leader in animal health, a position it has fortified since its historic decoupling from Pfizer over a decade ago. As of February 12, 2026,... 
Via Finterra
Topics Artificial Intelligence Earnings Economy
Zoetis Inc. (NYSE:ZTS) Reports Q4 Earnings Beat and Steady 2026 Guidance ↗
Via Chartmill
Topics Earnings
Zoetis Inc. (NYSE:ZTS): A Dependable Dividend Stock Built on Financial Strength ↗
Via Chartmill
News headline image
Zoetis’s (NYSE:ZTS) Q4 CY2025 Sales Top Estimates
Animal health company Zoetis (NYSE:ZTS) announced better-than-expected revenue in Q4 CY2025, with sales up 3% year on year to $2.39 billion. The company expects the full year’s revenue to be around... 
Via StockStory
News headline image
Zoetis Reports Fourth Quarter and Full Year 2025 Results
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis (ZTS) Reports Q4: Everything You Need To Know Ahead Of Earnings
Animal health company Zoetis (NYSE:ZTS) will be announcing earnings results this Thursday morning. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence
Zoetis Inc (NYSE:ZTS) Passes Key Quality Investing Screen ↗
Via Chartmill
ZOETIS INC (NYSE:ZTS) Stands Out as a Durable Dividend Stock for Income Investors ↗
Via Chartmill
News headline image
Should You Buy Zoetis Before Feb. 12? ↗
After walking back guidance last quarter, could this animal health company reveal surprises come earnings day? 
Via The Motley Fool
Topics Earnings
News headline image
Zoetis Declares Second Quarter 2026 Dividend
From Zoetis Inc.
Via Business Wire
News headline image
USDA Unveils $100 Million 'Grand Challenge' to Thwart Flesh-Eating Screwworm as Threat Reaches U.S. Border
In a decisive move to protect the nation’s multi-billion dollar livestock industry, U.S. Secretary of Agriculture Brooke Rollins announced today, February 5, 2026, the launch of a $100 million "New... 
Via MarketMinute
Topics Death Economy
News headline image
1 Cash-Producing Stock on Our Watchlist and 2 We Ignore
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
News headline image
2 Healthcare Stocks Poised for a Comeback in 2026 ↗
Don't wait too long to press the buy button on these comeback stories. 
Via The Motley Fool
News headline image
This Could Be One of the Best Healthcare Stock Buying Opportunities I've Seen in Years ↗
Trading at a once-in-a-decade low valuation, this leading animal healthcare stock deserves a long look from investors. 
Via The Motley Fool
News headline image
Q3 Earnings Roundup: Zoetis (NYSE:ZTS) And The Rest Of The Branded Pharmaceuticals Segment
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how branded pharmaceuticals stocks fared in Q3, starting with... 
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
2 of Wall Street’s Favorite Stocks with Solid Fundamentals and 1 Facing Challenges
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
1 Profitable Stock with Solid Fundamentals and 2 We Brush Off
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
Topics Bankruptcy
News headline image
Neogen Shares Skyrocket as Q2 Earnings Beat Signals Turning Point in 3M Integration Strategy
LANSING, MI – Shares of Neogen Corporation (NASDAQ: NEOG) experienced a dramatic surge in early trading today, climbing nearly 29% after the food and animal safety leader reported second-quarter fiscal... 
Via MarketMinute
Topics Earnings Economy
News headline image
The Paws-Solidation Era: How 2025 Became the Record-Breaking Year for Pet Care M&A
As 2025 comes to a close, the financial landscape of the pet care industry has been fundamentally reshaped by a tidal wave of mergers and acquisitions. What began as a post-pandemic stabilization... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
2 Safe-and-Steady Stocks with Competitive Advantages and 1 We Turn Down
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
News headline image
2 Beaten-Down Stocks That Could Bounce Back in 2026 ↗
It's not time to give up on these companies yet. 
Via The Motley Fool
News headline image
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2025 Financial Results
From Zoetis Inc.
Via Business Wire
News headline image
Prescription for Growth: Why Zoetis and Viatris are Defining Healthcare’s New Winners in 2025
As the curtain closes on 2025, the healthcare sector has emerged as a landscape of stark contrasts. While traditional pharmaceutical giants have grappled with the implementation of the Medicare Part D... 
Via MarketMinute
Topics Bonds Earnings World Trade
News headline image
Regulatory Roadblock: ImmuCell Pivots to Core Growth After FDA Rejects Mastitis Treatment
In a significant strategic shift that marks the end of a multi-year regulatory odyssey, ImmuCell Corporation (Nasdaq: ICCC) announced late yesterday, December 23, 2025, that it has received another... 
Via MarketMinute
News headline image
Got $5,000? These 3 Growth Stocks Are Trading Near Their Lows. ↗
Don't overlook these potential bargain buys -- they may not stay down for long. 
Via The Motley Fool
Topics Death
News headline image
Zoetis to Participate in the 44th Annual J.P. Morgan Healthcare Conference
From Zoetis Inc.
Via Business Wire
News headline image
These 2 Healthcare Stocks Just Declared Dividend Raises ↗
The healthcare industry has never been a great source of dividends -- that alone makes these companies exceptional. 
Via The Motley Fool
Topics Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.